Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HS-20110 Combination Therapy in Advanced Colorectal Cancer (Phase Ib/II)
CTR20254842Phase 2Active
- Sponsor
- Hansoh Pharmaceutical Group
- Start
- Jan 2026
- Modality
- Cytotoxic ADCs → Antibody-Drug Conjugates (ADCs) → Antibody Conjugates → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of HS-20110 in colorectal adenocarcinoma, sponsored by Hansoh Pharmaceutical Group. Started Jan 2026; status: active.
02
Drugs
HS-20110
03
Conditions
colorectal adenocarcinoma
Beyond the preview
Go deeper on CTR20254842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254842.